Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Bales

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Alzheimer'S Disease : JAD|October 27, 2004
Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP/PS double transgenic mouse model of Alzheimer's diseaseDavid A Costa, Lars N G Nilsson, Kelly R Bales, et al.
Science (New York, N.Y.)|March 23, 2002
Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's diseaseRonald B DeMattos, Kelly R Bales, David J Cummins, et al.
Neurobiology of Disease|April 13, 2002
Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's diseaseAnne M Fagan, Melanie Watson, Maia Parsadanian, et al.
Neurobiology of Aging|December 4, 2003
Use of YFP to study amyloid-beta associated neurite alterations in live brain slicesRobert P Brendza, Kelly Simmons, Kelly R Bales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 2005
Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's diseaseRichard E Hartman, Yukitoshi Izumi, Kelly R Bales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 27, 2002
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's diseaseRichard E Hartman, Helmut Laurer, Luca Longhi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 18, 2005
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic modelJohn D Fryer, Kelly Simmons, Maia Parsadanian, et al.
Journal of Chemical Neuroanatomy|March 30, 2010
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's diseaseCassia R Overk, Christian C Felder, Yuan Tu, et al.
The Journal of Biological Chemistry|October 7, 2005
Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer diseaseSuzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
The Journal of Clinical Investigation|February 25, 2006
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibodyKelly R Bales, Eleni T Tzavara, Su Wu, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Alzheimer'S Disease : JAD|October 27, 2004
Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP/PS double transgenic mouse model of Alzheimer's diseaseDavid A Costa, Lars N G Nilsson, Kelly R Bales, et al.
Science (New York, N.Y.)|March 23, 2002
Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's diseaseRonald B DeMattos, Kelly R Bales, David J Cummins, et al.
Neurobiology of Disease|April 13, 2002
Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's diseaseAnne M Fagan, Melanie Watson, Maia Parsadanian, et al.
Neurobiology of Aging|December 4, 2003
Use of YFP to study amyloid-beta associated neurite alterations in live brain slicesRobert P Brendza, Kelly Simmons, Kelly R Bales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 2005
Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's diseaseRichard E Hartman, Yukitoshi Izumi, Kelly R Bales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 27, 2002
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's diseaseRichard E Hartman, Helmut Laurer, Luca Longhi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 18, 2005
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic modelJohn D Fryer, Kelly Simmons, Maia Parsadanian, et al.
Journal of Chemical Neuroanatomy|March 30, 2010
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's diseaseCassia R Overk, Christian C Felder, Yuan Tu, et al.
The Journal of Biological Chemistry|October 7, 2005
Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer diseaseSuzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
The Journal of Clinical Investigation|February 25, 2006
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibodyKelly R Bales, Eleni T Tzavara, Su Wu, et al.
Pageof 7